Drug slashes cases of breast cancer in high-risk groups: Trial

Thousands of women considered most at risk for breast cancer could benefit from a Canadian-led trial that suggests one drug can significantly slash their risk of getting the disease.The clinical trial for the drug exemestane suggests it could reduce the risk of breast cancer in high-risk groups by about 65 per cent. The findings were published Saturday in the New England Journal of Medicine and are being described as “extremely exciting.�Some of the risk factors considered in the

Read more ...